| 摘要 |
Allergic and other immune disorders associated with antigen specific T cells are treated by administering a vaccine comprising sequences of a fusion protein of IL-18 and antigen. The methods are particularly useful in decreasing an established antigen specific IgE immune response. Conditions of particular interest include asthma, allergic rhinitis, IgE-mediated anaphylactic reactions to insect stings, and other allergic conditions. |
